InvestorsHub Logo
Followers 22
Posts 2520
Boards Moderated 0
Alias Born 01/07/2015

Re: None

Monday, 08/12/2019 8:06:06 AM

Monday, August 12, 2019 8:06:06 AM

Post# of 42
Net revenues of EMI for the 2019 second quarter increased 128% to $5.9 million, up from $2.6 million for the same period last year, and 11% from the first quarter of 2019. The increase was driven by the continuing roll-out and market acceptance of Endari®, the first treatment approved by the FDA for sickle cell disease in nearly 20 years.

https://www.prnewswire.com/news-releases/emmaus-life-sciences-reports-sharply-improved-2019-second-quarter-financial-results-300899734.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EMMA News